FDA 483 - ANI Pharmaceuticals Inc - December 06, 2024

A summary of the FDA 483 document cannot be generated as the provided content indicates that the document is empty and contains only page numbers, with no inspection report details available for processing. To create a summary including the company name, inspection dates, main violations, regulatory framework, and required actions, the full text of the FDA 483 inspection report is required.